Skip to content
Drug Regulatory Authority of Pakistan

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو |  English
  • facebook
  • twitter
  • envelope

Menu

  • About Us
    • DRAP at a Glance
    • Organization
    • Executive Management
    • Legislation
    • Boards and Committees
    • Quality Management System
  • Therapeutic Goods
    • Drugs
    • Medical Devices
    • Alternative Medicine
    • Controlled Substances
    • Emergency Use Authorizations
    • Clinical Trials Oversight
    • Licensing and Inspections
    • Quality Controls Labs
    • Import & Export
    • Advertisement Approvals
  • Safety Info
    • Product Recalls
    • Safety Communication
    • Safety Reporting
  • News & Updates
    • Regulatory Updates
    • Press Releases
    • Careers
    • Tenders
    • Events
  • Publications
    • Essential Medicine Lists
    • Guidelines
    • Newsletters
    • Regulatory Procedures
    • Regulatory Fees
    • Application Forms
    • Public Consultation
    • Minutes of the Meetings
  • E-Services
  • Medicine Availability
    • Public Medicine Shortage Reporting
    • Hospital Medicine Shortage Reporting
    • Focal Person Nomination
  • Support
    • Facilitation Desk
    • Complaints
    • Contact Us
Home > Articles by: Ijaz Mustafa

Author: Ijaz Mustafa

Priority Approval/Registration of Favipiravir Drugs During the COVID-19 Pandemic

Ijaz Mustafa COVID-19 July 14, 2020January 18, 2022
Favipiravir_priority-approval_registration-of-drugs-during-the-covid-19-pandemicDownload

Using Medicines Safely During the COVID-19(In Urdu)

Ijaz Mustafa COVID-19 July 7, 2020January 18, 2022
Safe-medicines-COVID-DRAP-UrduDownload

Using Medicines Safely During the COVID-19(In English)

Ijaz Mustafa COVID-19 July 7, 2020January 18, 2022
Safe-medicines-COVID-DRAP-EnglishDownload

Use of REMDESIVIR in the current COVID-19 Pandemic

Ijaz Mustafa COVID-19 June 19, 2020January 18, 2022
Use-of-remdesivir-in-the-current-covid-19-pandemic.-F-1Download

Priority Approval/Registration of Drugs Remdesivir and Tocilizumab During the COVID-19 pandemic

Ijaz Mustafa COVID-19 June 15, 2020January 18, 2022
Priority-Approval_Registration-of-Drugs-Remdesivir-and-Tocilizumab-During-the-COVID-19-pandemicDownload

Advisory on conduct of clinical trials during COVID-19 pandemic final

Ijaz Mustafa COVID-19 June 1, 2020January 18, 2022
Advisory-on-conduct-of-clinical-trials-during-covid-19-pandemic-finalDownload

Poster on how to wash hands properly(In Urdu)

Ijaz Mustafa COVID-19 May 11, 2020January 18, 2022
How_To_HandWash_Poster-DRAP-UrduDownload

Priority Approval / Registration of Drugs During the COVID-19 Pandemic

Ijaz Mustafa COVID-19 May 7, 2020January 18, 2022
Priority-ApprovalRegistration-of-Drugs-During-the-COVID-19-PandemicDownload

Recommendations for Interactions with Experimental COVID-19 Therapies

Ijaz Mustafa COVID-19 May 6, 2020January 18, 2022
Recommendations-for-Interactions-with-Experimental-COVID-19-TherapiesDownload

Consideration for Pharmacies and Medical Stores During the COVID-19

Ijaz Mustafa COVID-19 April 30, 2020January 18, 2022
Consideration-for-Pharmacies-and-Medical-Stores-During-the-COVID-19Download
  • ← Previous
  • Next →

Archives

  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • May 2019
  • February 2019
  • January 2019
  • December 2018
  • October 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • February 2018
  • November 2017
  • October 2017
  • July 2017
  • June 2017
  • May 2017
  • March 2017
  • November 2016
  • June 2016
  • March 2016
  • May 2014
  • March 2014
  • January 2014
  • October 2013
  • August 2013
  • April 2013
  • October 2012
  • July 2012
  • March 2012
  • February 2002

Meta

  • Log in

Quick Navigation

Archives

Drug Regulatory Authority of Pakistan

  • Islamabad | Karachi | Lahore | Peshawar | Quetta
  • Phone: 0800-03727 (Mon to Fri 08:30AM to 04:30PM)
  • Website: www.dra.gov.pk
Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan
  • Contact Us
  • Report a Problem